Floatz logo

Therapeutic Asset Ratings

5,098 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Lenvatinib
Endometrial Cancer
Merck Sharp & Dohme LLCP3B (61)
Lenvatinib
Neoplasm
Tongji HospitalP3B (61)
Leuporelin
Castration-Resistant Prostate Carcinoma
BayerP3B (61)
ly01005
Prostate Cancer
The First Affiliated Hospital of Xiamen UniversityP3B (61)
Maralixibat
Cholestasis
Mirum Pharmaceuticals, Inc.P3B (61)
Methotrexate
Acute Biphenotypic Leukemia
Fred Hutchinson Cancer CenterP3B (61)
Methotrexate
B-Cell Adult Acute Lymphocytic Leukemia
Massachusetts General HospitalP3B (61)
Methotrexate
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research NetworkP3B (61)
Methotrexate
Childhood Myelodysplastic Syndrome
Children's Oncology GroupP3B (61)
Msdc-0602K
Metabolic Dysfunction-Associated Steatohepatitis
Cirius Therapeutics, Inc.P3B (61)
Multiple Vitamins Injection
Skin Carcinoma
Women's College HospitalP3B (61)
N-Butyl Cyanoacrylate
Periampullary Adenocarcinoma
Minia UniversityP3B (61)
Neratinib
Breast Cancer
Xijing HospitalP3B (61)
Nivestim
Hodgkins Lymphoma
Thomas Jefferson UniversityP3B (61)
Nivestim
Follicular Lymphoma
Fred Hutchinson Cancer CenterP3B (61)
Ntla-2002
Hereditary Angioedema
Intellia TherapeuticsP3B (61)
Olaparib
Fallopian Tube Cancer
University of Colorado, DenverP3B (61)
Osimertinib
Neoplasm
Innovent Biologics (Suzhou) Co. Ltd.P3B (61)
Pcbhp
Breast Cancer
Fudan UniversityP3B (61)
Pelabresib
Cancer
Novartis PharmaceuticalsP3B (61)
Ponesimod
Multiple Sclerosis
BiogenP3B (61)
Ppsv23
Relapsing-Remitting Multiple Sclerosis
CelgeneP3B (61)
Pyrotinib
Colorectal Cancer
Anbogen Therapeutics, Inc.P3B (61)
Recombinant Human Hyaluronidase
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)P3B (61)
Rel-1017
Major Depressive Disorder
MGGM LLCP3B (61)
Showing 2576 to 2600 of 5,098 assets
PreviousPage 104 of 204Next